South Korea · Delayed Price · Currency is KRW OSTEONIC Statistics
Total Valuation
OSTEONIC has a market cap or net worth of KRW 83.55 billion. The enterprise value is 91.39 billion.
| Market Cap | 83.55B |
| Enterprise Value | 91.39B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
OSTEONIC has 20.06 million shares outstanding. The number of shares has increased by 1.38% in one year.
| Current Share Class | 20.06M |
| Shares Outstanding | 20.06M |
| Shares Change (YoY) | +1.38% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 21.13% |
| Owned by Institutions (%) | 6.71% |
| Float | 14.77M |
Valuation Ratios
The trailing PE ratio is 8.32 and the forward PE ratio is 6.61.
| PE Ratio | 8.32 |
| Forward PE | 6.61 |
| PS Ratio | 1.64 |
| PB Ratio | 1.16 |
| P/TBV Ratio | 1.24 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 7.79 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 8.96 |
| EV / Sales | 1.79 |
| EV / EBITDA | 7.16 |
| EV / EBIT | 10.30 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.27, with a Debt / Equity ratio of 0.40.
| Current Ratio | 2.27 |
| Quick Ratio | 1.36 |
| Debt / Equity | 0.40 |
| Debt / EBITDA | 2.28 |
| Debt / FCF | -47.16 |
| Interest Coverage | 7.11 |
Financial Efficiency
Return on equity (ROE) is 15.23% and return on invested capital (ROIC) is 9.66%.
| Return on Equity (ROE) | 15.23% |
| Return on Assets (ROA) | 5.35% |
| Return on Invested Capital (ROIC) | 9.66% |
| Return on Capital Employed (ROCE) | 10.33% |
| Weighted Average Cost of Capital (WACC) | 6.50% |
| Revenue Per Employee | 248.64M |
| Profits Per Employee | 49.78M |
| Employee Count | 205 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 1.24 |
Taxes
In the past 12 months, OSTEONIC has paid 1.70 billion in taxes.
| Income Tax | 1.70B |
| Effective Tax Rate | 14.29% |
Stock Price Statistics
The stock price has decreased by -42.71% in the last 52 weeks. The beta is 0.59, so OSTEONIC's price volatility has been lower than the market average.
| Beta (5Y) | 0.59 |
| 52-Week Price Change | -42.71% |
| 50-Day Moving Average | 4,417.30 |
| 200-Day Moving Average | 5,505.88 |
| Relative Strength Index (RSI) | 48.53 |
| Average Volume (20 Days) | 99,842 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, OSTEONIC had revenue of KRW 50.97 billion and earned 10.20 billion in profits. Earnings per share was 500.86.
| Revenue | 50.97B |
| Gross Profit | 24.56B |
| Operating Income | 8.87B |
| Pretax Income | 11.90B |
| Net Income | 10.20B |
| EBITDA | 12.77B |
| EBIT | 8.87B |
| Earnings Per Share (EPS) | 500.86 |
Balance Sheet
The company has 21.34 billion in cash and 29.06 billion in debt, with a net cash position of -7.72 billion or -385.02 per share.
| Cash & Cash Equivalents | 21.34B |
| Total Debt | 29.06B |
| Net Cash | -7.72B |
| Net Cash Per Share | -385.02 |
| Equity (Book Value) | 72.05B |
| Book Value Per Share | 3,585.82 |
| Working Capital | 35.35B |
Cash Flow
In the last 12 months, operating cash flow was 10.73 billion and capital expenditures -11.34 billion, giving a free cash flow of -616.14 million.
| Operating Cash Flow | 10.73B |
| Capital Expenditures | -11.34B |
| Depreciation & Amortization | 3.90B |
| Net Borrowing | 5.20B |
| Free Cash Flow | -616.14M |
| FCF Per Share | -30.71 |
Margins
Gross margin is 48.18%, with operating and profit margins of 17.40% and 20.02%.
| Gross Margin | 48.18% |
| Operating Margin | 17.40% |
| Pretax Margin | 23.35% |
| Profit Margin | 20.02% |
| EBITDA Margin | 25.05% |
| EBIT Margin | 17.40% |
| FCF Margin | n/a |
Dividends & Yields
OSTEONIC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.38% |
| Shareholder Yield | -1.38% |
| Earnings Yield | 12.21% |
| FCF Yield | -0.74% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 24, 2020. It was a forward split with a ratio of 1.5.
| Last Split Date | Jun 24, 2020 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
OSTEONIC has an Altman Z-Score of 2.99 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.99 |
| Piotroski F-Score | 6 |